Antibody Penetration
Antibody Penetration - Related Videos
10:12
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
0 Views •
Cited by 5 •
2022
This protocol describes the synthesis of cyclic cell-penetrating peptides with aromatic cross-links and the evaluation of their permeability across biological barriers.
08:39
Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
0 Views •
Cited by 8 •
2017
The goal of this protocol is to alter the penetrance of lethal skeletal mutant phenotypes in zebrafish by selective breeding. Lethal mutants cannot be grown to adulthood and bred themselves, therefore this protocol describes a method for tracking and selecting penetrance through multiple generations by progeny testing.
03:30
Inducing Penetrating Traumatic Brain Injury in Adult Drosophila Flies
0 Views •
2025
This video demonstrates the induction of penetrating traumatic brain injury in the drosophila brain. Newly emerged flies are selected, anesthetized, and positioned under a fluorescence-equipped stereo microscope. The GFP-expressing mushroom body is identified, and a Minutien pin is inserted to cause injury. The flies are allowed to recover for further studies.
02:58
Fluorescence Leakage Assay to Study Cell-Penetrating Peptide Interaction with Membrane
0 Views •
2025
This video discusses the fluorescence leakage assay to study the interactions of cell-penetrating peptides with cell membranes using cell membrane mimics — large unilamellar vesicles, or LUVs, encapsulated with a fluorescent dye and a quencher.
13:21
Antibody Generation: Producing Monoclonal Antibodies Using Hybridomas
0 Views •
2023
Source: Frances V. Sjaastad1,2, Whitney Swanson2,3, and Thomas S. Griffith1,2,3,4 1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Department of Urology, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Polyclonal antibodies are defined as a collection of antibodies directed against...
FAQs
These molecular properties affect how readily antibodies move through tissue spaces and how strongly they remain associated with available targets. Size can limit passage through restrictive structures, while charge influences interactions with tissue components. Affinity affects target binding and localization, so penetration and retention must be considered together when evaluating whether antibodies can reach and engage targets effectively.
Antibody movement after reaching a tissue can occur through diffusion, convection, or receptor-mediated uptake. Diffusion reflects movement through available spaces, convection depends on fluid movement, and receptor-mediated uptake involves interactions with cellular receptors. The relative contribution of these processes helps explain why antibody distribution may vary between tissues and why access to intracellular or tissue-associated targets can be limited.
Dense extracellular matrices can obstruct movement through tissue, while limited blood flow reduces delivery to some regions. Variation in vascular permeability adds another layer of heterogeneity, allowing antibodies to enter certain areas more readily than others. Consequently, an antibody may accumulate near accessible regions yet show weaker localization elsewhere, producing uneven target exposure within the same tumor or tissue.
Target engagement depends not only on whether an antibody recognizes its target, but also on whether sufficient antibody reaches the relevant location. Restricted transport, poor vascular access, or strong interactions with tissue components can reduce local availability. Assessing penetration alongside binding therefore helps distinguish inadequate tissue access from weak target recognition when localization or biological response appears limited.
Immunostaining design should account for antibody movement through the sample and access to the target, rather than treating binding as the only determinant of signal. Molecular size, charge, affinity, tissue structure, and transport processes can influence localization. Considering these variables helps interpret uneven staining and supports protocol choices aimed at improving antibody access within biological specimens.
In imaging and diagnostic studies, penetration helps determine whether an antibody reaches the site needed for detectable target localization. In therapeutic development, the same considerations guide assessment of tissue access and target engagement. Researchers can use information about vascular permeability, blood flow, extracellular matrix density, and transport mechanisms to interpret distribution patterns and identify limitations affecting performance.